Home › NDC Lookup › RxCUI directory › RxCUI 211140

Pentosan polysulfate 100 MG Oral Capsule [Elmiron] — RxCUI 211140

RxNorm drug concept · Semantic branded drug
RxCUI 211140 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI211140
Official namePentosan polysulfate 100 MG Oral Capsule [Elmiron]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asElmiron 100 MG Oral Capsule
FDA products mapped1
Package NDCs mapped1
Reported Medicaid activity (SDUD)9,962 prescriptions · 42 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Pentosan Polysulfate: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Elmiron is the brand name for pentosan polysulfate sodium, and it's specifically approved to relieve bladder pain and discomfort caused by interstitial cystitis — a chronic conditi...
  • Elmiron is not a fast-acting drug. Your prescriber will typically check in with you after 3 months to see if it's helping. If you haven't noticed improvement by 6 months, the evide...
  • How long does it take for Elmiron to start working?
  • Yes — this is the most important thing to know about long-term Elmiron use. The drug has been linked to changes in the retina (the back of the eye) called pigmentary maculopathy, w...
📖 Read our full Pentosan Polysulfate guide →

🕸️ Concept Web — How Pentosan polysulfate 100 MG Oral Capsule [Elmiro... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Pentosan polysulfate 100 MG Oral Capsule [Elmiron] RxCUI 211140

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Pentosan polysulfate 155046
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Elmiron 155043
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Pentosan polysulfate Oral Capsule 373284
    • Pentosan polysulfate Oral Product 1165405
    • Pentosan polysulfate Pill 1165406
    • Pentosan polysulfate Oral Capsule [Elmiron] 366513
    • Elmiron Oral Product 1174622
    • Elmiron Pill 1174623
    • Oral Capsule 316965
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Pentosan polysulfate 100 MG Oral Capsule SCD · 199498
  • Pentosan polysulfate 100 MG SCDC · 330108
  • Pentosan polysulfate Oral Capsule SCDF · 373284
  • Pentosan polysulfate Oral Product SCDG · 1165405
  • Pentosan polysulfate Pill SCDG · 1165406

Brand-Name Concepts

  • Pentosan polysulfate 100 MG [Elmiron] SBDC · 571599
  • Pentosan polysulfate Oral Capsule [Elmiron] SBDF · 366513
  • Elmiron Oral Product SBDG · 1174622
  • Elmiron Pill SBDG · 1174623
  • Elmiron BN · 155043

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 211140 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
50458-0098-01 100 CAPSULE, GELATIN COATED in 1 BOTTLE (50458-098-01) ELMIRON Janssen Pharmaceuticals, Inc. 1996-09-26
Observed labelers: Janssen Pharmaceuticals, Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ea · median
$12.0956
Range $12.0956–$12.0956 · middle 50% $12.0956–$12.0956 · 1 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.